A comprehensive view of Generics / Biosimilars. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Sun Pharma offers to purchase Israeli generic drug company Taro Pharmaceutical Industries in deal valued at US$1.4B; Taro currently holds 78.5% stake in Taro

The cost of a pack of generic drugs in Portugal was 58% lower than average price of original drug in 2022; generics had 49% market share in Portugal in 2022 and held 25% of market value with sales of €811M: market study

Amgen sues Novartis' Sandoz for biosimilar's alleged infringement on bone drugs Xgeva, Prolia; Amgen alleges Sandoz did not provide details about biosimilar's manufacturing process as required by law and that FDA approval may come before patents expire

Juno Pharmaceuticals acquires Omega Labs to become largest specialty generic injectable provider in Canada; Juno plans to introduce 100 new products to Canadian market in the next 4 years

Generic sterile injectables market projected to grow from US$68.7B in 2019 to US$196.2B by 2029, have 11.2% CAGR growth; growth due to prevalence of chronic diseases and increasing number of drug manufacturers focused on cancer and rapid FDA

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count